Bio-Rad Laboratories logo

Bio-Rad Laboratories

BIO | NYSE
Chart Builder DCF Calculator
$360.26
-$6.10 (-1.67%)
At close: Nov 16, 2026, 4:00 PM ET
$360.26
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:05 PM ET
-1.67%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
60.8
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #128/1021 (Top 13%)

Key Statistics

Market Data

Market Cap $9.69B
1D Range
358.49 365.61
52W Range
241.71 390.34

Valuation (TTM)

PE 9.49
PB 1.27
EV/EBITDA 6.34

Valuation (NTM)

Forward PE 36.71
Forward PEG -7.35
Price Target $350.00
Loading financial charts...

Profile

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span ...

Sector Healthcare
Employees 7,450
IPO Date Feb 27, 1980
Fiscal Year January - December

Latest News

BIO-key Q3 Software License Fees Grew 39%, Its Third Consecutive Quarter of Double-Digit Growth, Driven Primarily by Momentum in the Middle East and Europe; Hosts Call Today at 10am ET

3 days ago · globenewswire.com

BIO-key Q3 Software License Fees Grew 39%, Its Third Consecutive Quarter of Double-Digit Growth, Driven Primarily by Momentum in the Middle East and Europe; Hosts Call Today at 10am ET
BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

4 days ago · globenewswire.com

BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
BIO-key Enters Gaming / Hospitality Market with Contract from Major U.S. Casino Resort

5 days ago · globenewswire.com

BIO-key Enters Gaming / Hospitality Market with Contract from Major U.S. Casino Resort
Bio-Rad Laboratories, Inc. (BIO) Presents at 2026 UBS Global Healthcare Conference Transcript

6 days ago · seekingalpha.com

Bio-Rad Laboratories, Inc. (BIO) Presents at 2026 UBS Global Healthcare Conference Transcript
Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Alpha-Lactalbumin for Premium Nutrition Markets in the U.S.

6 days ago · globenewswire.com

Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Alpha-Lactalbumin for Premium Nutrition Markets in the U.S.
Why Bio-Rad (BIO) International Revenue Trends Deserve Your Attention

8 days ago · zacks.com

Why Bio-Rad (BIO) International Revenue Trends Deserve Your Attention

12 days ago · globenewswire.com

Medicus Pharma to Present at BIO-Europe 2026
What Bio-Rad Laboratories (BIO) Said on Its Q3 Earnings Call

12 days ago · marketbeat.com

What Bio-Rad Laboratories (BIO) Said on Its Q3 Earnings Call
Bio-Rad Laboratories, Inc. (BIO) Q3 2026 Earnings Call Transcript

12 days ago · seekingalpha.com

Bio-Rad Laboratories, Inc. (BIO) Q3 2026 Earnings Call Transcript
Bio-Rad Laboratories (BIO) Q3 Earnings Top Estimates

12 days ago · zacks.com

Bio-Rad Laboratories (BIO) Q3 Earnings Top Estimates

Earnings

Latest Earnings
Nov 4, 2026
EPS
$2.65
Beat +18.83%
REV
$656.4M
Beat +0.99%
Next Earnings
Feb 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Hold
Price Target
$350.00
Downside
-2.85%
Buy (1)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.